superph net
superph net
President-elect Donald Trump’s vow to curtail big tech’s power aligns with about three-quarters of Americans who are concerned about its vast influence, according to a JL Partners poll obtained exclusively by Breitbart News. Seventy-four percent of Americans are very or somewhat worried about big tech’s influence on politics, the economy, and the lives of average Americans, the poll found. Fifteen percent are a little concerned, with just seven percent not at all concerned. Seventy-eight percent are worried about big tech’s expenditure of hundreds of millions of dollars to influence government policymaking. The poll sampled 1,000 registered voters from November 15-18 with a 3.1 percentage point margin of error. The survey comes as Trump vowed to reduce big tech’s power if he won reelection. Trump warned Facebook during the 2024 campaign against a repeat performance. “CEASE & DESIST: I, together with many Attorneys and Legal Scholars, am watching the Sanctity of the 2024 Presidential Election very closely because I know, better than most, the rampant Cheating and Skullduggery that has taken place by the Democrats in the 2020 Presidential Election. It was a Disgrace to our Nation!” Trump posted in September. “Therefore, the 2024 Election, where Votes have just started being cast, will be under the closest professional scrutiny and, WHEN I WIN, those people that CHEATED will be prosecuted to the fullest extent of the Law, which will include long term prison sentences so that this Depravity of Justice does not happen again. We cannot let our Country further devolve into a Third World Nation, AND WE WON’T!” Trump has a history of pushing back against big tech. During Trump’s first term, his Justice Department and several Republican-controlled states filed an antitrust lawsuit against Google. Trump called the search results “election interference.” “It has been determined that Google has illegally used a system of only revealing and displaying bad stories about Donald J. Trump, some made up for this purpose while, at the same time, only revealing good stories about Comrade Kamala Harris,” Trump posted on Truth Social. “This is an ILLEGAL ACTIVITY, and hopefully the Justice Department will criminally prosecute them for this blatant Interference of Elections.” “If not, and subject to the Laws of our Country, I will request their prosecution, at the maximum levels, when I win the Election, and become President of the United States!” he concluded. Wendell Husebo is a political reporter with Breitbart News and a former RNC War Room Analyst. He is the author of Politics of Slave Morality. Follow Wendell on “X” @WendellHusebø or on Truth Social @WendellHusebo.
HIGH POINT 81, PFEIFFER 50
Charleston Southern grabs late lead, stuns host MiamiSARATOGA SPRINGS, N.Y. — The Section 2 boys soccer banquet was held Sunday, Dec. 8, at the Saratoga Holiday Inn. There was a large school banquet and a small school banquet with more than 550 people attending. Below are the awards from the banquet.The Golden Thread Award is presented to someone who has gone above [...]
CARLSBAD, Calif. , Dec. 12, 2024 /PRNewswire/ -- Ourself, a leader in the next generation of skincare, today announced that clinical data evaluating Ourself's patented delivery technology, Tiered-Release VesiclesTM (TRVs), was published in Dermatologic Surgery , the official journal of the American Society for Dermatologic Surgery. The publication highlights that TRVs have the potential to revolutionize skincare by enabling the delivery of large, bioactive molecules directly into the epidermis and dermis. The Ourself delivery method promises to reshape the way we care for our skin and opens new possibilities for enhancing cosmetic outcomes topically. "Publication of this data reinforces that Ourself is setting a new standard in topical delivery," said Jim Hartman , Ourself's Chief Executive Officer. "We are excited to lead these advancements and look forward to the growth and innovation this breakthrough will inspire for our brand and the industry as a whole." "Tiered-Release Vesicles represent a revolutionary advancement in dermal delivery technology, addressing a stagnation in the industry that has persisted for over four decades," said Ashish C. Bhatia , MD, FAAD, author and board-certified dermatologist and Mohs surgeon at Oak Dermatology. For decades, the skin's outermost layer, the stratum corneum, has long been a barrier that limits the effectiveness of skincare products, blocking essential ingredients from reaching deeper layers. Traditional delivery systems like liposomes have failed to penetrate deeply enough to achieve substantial results—TRVs change this paradigm. "It's not just about the ingredients but also how the ingredients get to where they need to go. Ourself is revolutionary and a game changer in our industry because we've had the same delivery systems for 40 years. Now we have something better," said Amy B. Lewis , MD, board-certified dermatologist at Lewis Dermatology and Associates. "The Tiered-Release Vesicle delivery system is a major step forward for skincare. These developments redefine what is now achievable in topical delivery, unlocking limitless potential for the future of skincare," said Amir Moradi , MD, MBA lead author and double board-certified facial plastic and otolaryngology-head and neck surgeon at Moradi MD. ABOUT OURSELF Leveraging decades of biotech and skincare expertise, Ourself developed a new, scientifically advanced delivery technology to broaden the capabilities of cosmetic skincare forever. Utilizing patented Tiered-Release VesiclesTM, Ourself "hero" products ensure deep ingredient delivery, sending larger molecules, powerful peptides and all-in-one formulations directly to the layer of the skin where they're needed most to improve loss of volume, lines & wrinkles, and uneven pigmentation. Ourself developed the first non-injectable Lip Filler clinically proven to restore volume by delivering two sizes of hyaluronic acid into the lips, topically. Ourself is based in Carlsbad, CA. For more information, visit Ourself.com . REFERENCE: Moradi A, et al. In Vivo and Ex Vivo Evaluation of a Novel Method for Topical Delivery of Macromolecules Through the Stratum Corneum for Cosmetic Applications. Dermatol Surg. 2024 View original content to download multimedia: https://www.prnewswire.com/news-releases/clinical-validation-of-ourself-delivery-technology-published-in-dermatologic-surgery--tiered-release-vesicles-poised-to-revolutionize-skincare-302330774.html SOURCE OurselfChamber of Commerce addresses Facebook event confusion
